JP2013535472A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535472A5 JP2013535472A5 JP2013521961A JP2013521961A JP2013535472A5 JP 2013535472 A5 JP2013535472 A5 JP 2013535472A5 JP 2013521961 A JP2013521961 A JP 2013521961A JP 2013521961 A JP2013521961 A JP 2013521961A JP 2013535472 A5 JP2013535472 A5 JP 2013535472A5
- Authority
- JP
- Japan
- Prior art keywords
- timolol
- bimatoprost
- composition
- preservative
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 claims description 29
- 229960004605 timolol Drugs 0.000 claims description 29
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 claims description 25
- 229960002470 bimatoprost Drugs 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 230000004410 intraocular pressure Effects 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 claims description 5
- 229960002303 citric acid monohydrate Drugs 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- WLRMANUAADYWEA-NWASOUNVSA-N (S)-timolol maleate Chemical compound OC(=O)\C=C/C(O)=O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 WLRMANUAADYWEA-NWASOUNVSA-N 0.000 claims description 2
- 208000010412 Glaucoma Diseases 0.000 claims description 2
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 229960005221 timolol maleate Drugs 0.000 claims description 2
- 229940061607 dibasic sodium phosphate Drugs 0.000 claims 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 2
- 239000000243 solution Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- PYLIXCKOHOHGKQ-UHFFFAOYSA-L disodium;hydrogen phosphate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O PYLIXCKOHOHGKQ-UHFFFAOYSA-L 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000007951 isotonicity adjuster Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- ZQNPDAVSHFGLIQ-UHFFFAOYSA-N calcium;hydrate Chemical compound O.[Ca] ZQNPDAVSHFGLIQ-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940052354 dibasic sodium phosphate heptahydrate Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- -1 silver ions Chemical class 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36868510P | 2010-07-29 | 2010-07-29 | |
| US61/368,685 | 2010-07-29 | ||
| PCT/US2011/045654 WO2012015998A2 (en) | 2010-07-29 | 2011-07-28 | Preservative free bimatoprost and timolol solutions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013535472A JP2013535472A (ja) | 2013-09-12 |
| JP2013535472A5 true JP2013535472A5 (https=) | 2016-03-17 |
| JP6014033B2 JP6014033B2 (ja) | 2016-10-25 |
Family
ID=44504226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013521961A Active JP6014033B2 (ja) | 2010-07-29 | 2011-07-28 | 防腐剤無添加ビマトプロストおよびチモロール溶液 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9078854B2 (https=) |
| EP (2) | EP3431074B1 (https=) |
| JP (1) | JP6014033B2 (https=) |
| KR (1) | KR101820184B1 (https=) |
| CN (1) | CN103068364B (https=) |
| AU (1) | AU2011282681B2 (https=) |
| CA (1) | CA2807081C (https=) |
| DK (1) | DK2598118T3 (https=) |
| ES (2) | ES2708451T3 (https=) |
| HR (1) | HRP20220626T1 (https=) |
| HU (2) | HUE059325T2 (https=) |
| PL (1) | PL2598118T3 (https=) |
| PT (2) | PT2598118T (https=) |
| RU (1) | RU2624534C2 (https=) |
| SI (2) | SI2598118T1 (https=) |
| WO (1) | WO2012015998A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9061034B2 (en) * | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
| KR101820184B1 (ko) | 2010-07-29 | 2018-01-18 | 알러간, 인코포레이티드 | 방부제가 없는 비마토프로스트 및 티몰롤 용액 |
| US9248135B2 (en) | 2012-04-24 | 2016-02-02 | Allergan, Inc. | Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use |
| EP3057575B1 (en) | 2013-10-15 | 2021-09-08 | Pharmathen S.A. | Preservative free pharmaceutical compositions for ophthalmic administration |
| GR1008483B (el) * | 2013-12-23 | 2015-05-12 | Rafarm Α.Ε.Β.Ε., | Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης |
| GR1009006B (el) * | 2016-04-01 | 2017-04-04 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χρηση περιεχον βιματοπροστη και τιμολολη |
| PL431139A1 (pl) * | 2019-09-13 | 2021-03-22 | Warszawskie Zakłady Farmaceutyczne Polfa Spółka Akcyjna | Kompozycja farmaceutyczna bimatoprostu i tymololu |
| US11786538B2 (en) | 2019-12-11 | 2023-10-17 | Somerset Therapeutics, Llc | Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties |
| KR20220100194A (ko) | 2021-01-08 | 2022-07-15 | 이동혁 | 식품 방부제 스티커 |
| US12064440B2 (en) | 2022-03-21 | 2024-08-20 | Somerset Therapeutics, Llc | Ophthalmic gel compositions of bimatoprost and timolol and associated methods |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US368685A (en) | 1887-08-23 | peahae | ||
| US4599353A (en) | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
| DE3220156C2 (de) | 1982-05-28 | 1990-01-25 | Heida Houston Tex. Thurlow | Mit Metallgriffen, insbesondere Edelstahlgriffen, versehenes Koch- und Bratgeschirr mit Deckel |
| CH665587A5 (de) | 1984-11-07 | 1988-05-31 | Wiederkehr Hans | Schleifkopf. |
| DE3871596T3 (de) | 1987-04-03 | 2000-09-07 | Pharmacia & Upjohn Ab, Stockholm | Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes. |
| WO1990002553A1 (en) | 1988-09-06 | 1990-03-22 | Pharmacia Ab | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| US4994274A (en) | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
| US5028624A (en) | 1989-07-27 | 1991-07-02 | Allergan, Inc. | Intraocular pressure reducing 9,15-diacyl prostaglandins |
| US5034413A (en) | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
| DK0458590T3 (da) | 1990-05-22 | 1996-02-05 | R Tech Ueno Ltd | Behandling af okulær hypertension med en synergistisk konbination |
| RO113612B1 (ro) | 1991-04-17 | 1998-09-30 | Merck & Co Inc | Compozitie oftalmica |
| SG84487A1 (en) | 1991-04-17 | 2001-11-20 | Merck & Co Inc | Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a b-adrenergic antagonist |
| US5352708A (en) | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5688819A (en) * | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| JPH06107547A (ja) | 1992-10-01 | 1994-04-19 | Aarutetsuku Ueno:Kk | 眼科用組成物 |
| US5268624A (en) | 1992-10-14 | 1993-12-07 | Allergan, Inc. | Foot pedal control with user-selectable operational ranges |
| US6184250B1 (en) | 1993-08-03 | 2001-02-06 | Alcon Laboratories, Inc. | Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
| EP0891712A1 (en) | 1993-12-20 | 1999-01-20 | Biopolymerix, Inc. | Liquid dispenser for sterile solutions |
| US6051576A (en) | 1994-01-28 | 2000-04-18 | University Of Kentucky Research Foundation | Means to achieve sustained release of synergistic drugs by conjugation |
| EP1057486A1 (en) | 1995-11-17 | 2000-12-06 | Alcon Laboratories, Inc. | Use of drug combination for treating Glaucoma |
| US6071904A (en) | 1996-12-11 | 2000-06-06 | Alcon Laboratories, Inc. | Process for manufacturing ophthalmic suspensions |
| JP2002521332A (ja) | 1998-07-21 | 2002-07-16 | メルク エンド カムパニー インコーポレーテッド | 高眼圧治療用眼薬組成物 |
| HK1040184A1 (zh) | 1999-03-12 | 2002-05-31 | Alcon Laboratories, Inc. | 治療青光眼之組合療法 |
| KR20040008174A (ko) | 2001-05-14 | 2004-01-28 | 수캄포 아게 | 고안압증 및 녹내장 치료방법 |
| TWI298257B (en) | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
| US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
| WO2006041875A1 (en) * | 2004-10-06 | 2006-04-20 | Allergan, Inc. | Novel prostamides for the treatment of glaucoma and related diseases |
| ES2232319B1 (es) | 2004-10-15 | 2006-08-16 | Fico Mirrors, S.A. | Metodo de control de un espejo electrocromico y sistema electrocromico, aplicables a un vehiculo automovil. |
| US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| PT1937212E (pt) * | 2005-10-10 | 2010-11-30 | Novagali Pharma Sa | Emulsões oftálmicas contendo prostaglandinas |
| FR2918891B1 (fr) | 2007-07-20 | 2009-09-25 | Thea Sa Lab | Solution ophtalmique a base de prostaglandines sans conservateur |
| US7469624B1 (en) | 2007-11-12 | 2008-12-30 | Jason Adams | Direct drive retrofit for rifles |
| EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
| US8309635B2 (en) * | 2009-07-31 | 2012-11-13 | Chemtura Corporation | Solid alkylaryl phosphite compositions and methods for manufacturing same |
| KR101820184B1 (ko) | 2010-07-29 | 2018-01-18 | 알러간, 인코포레이티드 | 방부제가 없는 비마토프로스트 및 티몰롤 용액 |
| US9061034B2 (en) * | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
-
2011
- 2011-07-28 KR KR1020137004813A patent/KR101820184B1/ko active Active
- 2011-07-28 DK DK11745860.4T patent/DK2598118T3/en active
- 2011-07-28 SI SI201131614T patent/SI2598118T1/sl unknown
- 2011-07-28 ES ES11745860T patent/ES2708451T3/es active Active
- 2011-07-28 HU HUE18182158A patent/HUE059325T2/hu unknown
- 2011-07-28 AU AU2011282681A patent/AU2011282681B2/en active Active
- 2011-07-28 HR HRP20220626TT patent/HRP20220626T1/hr unknown
- 2011-07-28 JP JP2013521961A patent/JP6014033B2/ja active Active
- 2011-07-28 RU RU2013107744A patent/RU2624534C2/ru active
- 2011-07-28 SI SI201132054T patent/SI3431074T1/sl unknown
- 2011-07-28 PT PT11745860T patent/PT2598118T/pt unknown
- 2011-07-28 WO PCT/US2011/045654 patent/WO2012015998A2/en not_active Ceased
- 2011-07-28 EP EP18182158.8A patent/EP3431074B1/en active Active
- 2011-07-28 CA CA2807081A patent/CA2807081C/en active Active
- 2011-07-28 ES ES18182158T patent/ES2911174T3/es active Active
- 2011-07-28 PT PT181821588T patent/PT3431074T/pt unknown
- 2011-07-28 PL PL11745860T patent/PL2598118T3/pl unknown
- 2011-07-28 CN CN201180040407.1A patent/CN103068364B/zh active Active
- 2011-07-28 EP EP11745860.4A patent/EP2598118B1/en not_active Revoked
- 2011-07-28 US US13/812,597 patent/US9078854B2/en active Active
- 2011-07-28 HU HUE11745860A patent/HUE040488T2/hu unknown
-
2015
- 2015-06-08 US US14/733,118 patent/US20160113934A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013535472A5 (https=) | ||
| JP2025176149A (ja) | アトロピン含有水性組成物 | |
| JP6014033B2 (ja) | 防腐剤無添加ビマトプロストおよびチモロール溶液 | |
| JP2002003364A (ja) | 点眼剤、眼科用組成物及び吸着抑制方法 | |
| JP7630944B2 (ja) | ブリモニジンとチモロールとを含む、緑内障罹患患者における眼圧を下降させるための組成物 | |
| JP2012520882A5 (https=) | ||
| JP2014012744A (ja) | 望ましい生物学的利用能を有する薬学的組成物 | |
| JP2019530729A5 (https=) | ||
| JP2020073606A (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤 | |
| JP2023168547A (ja) | 眼科組成物 | |
| JP2014515383A5 (https=) | ||
| JP2019123714A (ja) | 点眼剤 | |
| JP2021522264A (ja) | 抗微生物有効性の増強及び毒性の減少を有する亜塩素酸ナトリウム組成物 | |
| JP2003206241A (ja) | 眼科用剤 | |
| JP7599838B2 (ja) | エピナスチン又はその塩を含有する水性医薬組成物 | |
| JP7247278B2 (ja) | 水性医薬組成物 | |
| EP2598117A2 (en) | Preservative free bimatoprost solutions | |
| JP6449774B2 (ja) | 両性イオン性ソフトコンタクトレンズ用眼科用組成物 | |
| JP2002114686A (ja) | 点眼剤組成物 | |
| JP5834427B2 (ja) | ソフトコンタクトレンズへの吸着抑制方法 | |
| JP2009029779A (ja) | レボカバスチン及び／又はその塩を含有する水性医薬組成物 | |
| JP4801300B2 (ja) | 外用液状組成物 | |
| JP2015067607A (ja) | 複数の成分を配合した点眼剤 | |
| JP6449773B2 (ja) | 陰イオン性ソフトコンタクトレンズ用眼科用組成物 | |
| WO2008036258A2 (en) | Collyrium for dry eye |